DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/kdhp9b/global_male) has announced the addition of the "Global Male Infertility Market (Techniques and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020" report to their offering.
The male infertility market is expected to grow to $301.5 million by 2020 with a CAGR of 4.9% during 2013-2020
Male infertility is defined as the inability of a male to impregnate his female partner after a year of unprotected intercourse. 20% of the total infertility is due to male factors. The major factors driving the male infertility market are the change in lifestyle, increasing age, environmental effects, etc., and these factors are majorly contributing to the rise in male infertility levels.
The major limitation experienced in the male infertility market is due to repeated treatment failures leading to an emotional impact on the patient. The repeated failures would compel most patients to discontinue the treatment. The other limitation is the social taboo. Out of 32-40% infertile men, only 15% of the men opt for the treatment for infertility due to the embarrassment, guilt, etc.
The opportunity driving the market is medical tourism and increase in awareness about male infertility. The treatment for male infertility is expensive; however, the cost of the treatment is expected to decrease with the advancement in treatment technologies. The other factor that may drag the prices lower would be the patients' expectations for cost effective treatments. These factors would drive the male infertility market.
MARKET BY TECHNIQUES
- DNA Fragmentation Technique
- Oxidative Stress Analysis
- Microscopic Examination
- Sperm Penetration Assay
- Sperm Agglutination
- Computer Assisted Semen Analysis
- Access Pharmaceuticals
- Andrology Solutions.
- ASKA Pharmaceutical Co. Ltd
- Cordex Pharma
- Halotech DNA SL
- Intas Pharmaceuticals Ltd.
- Merck Serono
- Pantarhei Bioscience B
- SCSA diagnostics
- ZydusCadila Healthcare Limited
For more information visit http://www.researchandmarkets.com/research/kdhp9b/global_male